The U.S. Food and Drug Administration approved 2025-26 COVID-19 vaccines for anyone age 65 and older and any person 6 months and older who has at least one underlying health condition that increases ...

A new COVID-19 variant that was unheard of just months ago is now projected to be the second-most common strain in the United States. Variant NB.1.8.1 was first detected in China in January but ...

As respiratory virus season approaches, you may be wondering if you should get the new COVID-19 vaccine to protect yourself. However, it may be more difficult for some people to find the shot this ...

EDITOR’S NOTE: This story has been updated to reflect changes to US Centers for Disease Control and Prevention immunization schedules. The US Department of Health and Human Services, under Secretary ...

Novel Coronavirus (COVID-19) The COVID-19 pandemic caused by the novel coronavirus (SARS-CoV-2) continues to reshape the globe. Stay current with the latest updates essential for healthcare ...

Under the control of anti-vaccine advocate Robert F. Kennedy Jr., the Food and Drug Administration is unilaterally terminating universal access to seasonal COVID-19 vaccines; instead, only people who ...

This year’s updated Covid-19 vaccines have been approved by the US Food and Drug Administration for adults 65 and older and younger people with certain medical conditions that put them at a higher ...

Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, ...

Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine New antiviral drugs in development could offer the ...